7/7/2019 TransEnterix (TRXC): The 1 Billion Dollar Joke – Street


thestreetsweeper.org/transenterix-trxc-the-1-billion-dollar-joke/ 1/11


Home  Blog 2  Uncategorized  TransEnterix (TRXC): The 1 Billi


TRANSENTERIX (TRXC): 
DOLLAR JOK


Public Oath Clean Up Crew Legal Disclaimer


TRANSENTERIX (TRXC): THE 1 BILLION DOLLAR JOKE OBSCENE INTROGEN BOMB?



http://thestreetsweeper.org/

http://thestreetsweeper.org/blog-2/

http://thestreetsweeper.org/category/uncategorized/

http://thestreetsweeper.org/transenterix-trxc-the-1-billion-dollar-joke/

http://thestreetsweeper.org/

http://thestreetsweeper.org/public-oath/

http://thestreetsweeper.org/clean-up-crew/

http://thestreetsweeper.org/legal-disclaimer/

http://thestreetsweeper.org/investment-tools/

http://thestreetsweeper.org/transenterix-trxc-the-1-billion-dollar-joke/

http://thestreetsweeper.org/obscene-insider-selling-of-galectin-therapeutics-galt-lost-confidence/

http://thestreetsweeper.org/genprex-gnpx-another-introgen-bomb/
7/7/2019 TransEnterix (TRXC): The 1 Billion Dollar Joke – Street


thestreetsweeper.org/transenterix-trxc-the-1-billion-dollar-joke/ 2/11


 


How can a company like TransEnterix (TRXC) –  offering just $3.5 million in sales last quarter 


Whatever measurement we use, TheStreetSweeper can’t justify this kind of market valuation fo
 company.


/  0/  Sonya Colberg


TRANSENTERIX (TRXC): THE 1 BILLION DOLLAR JOKE


27
JUN  



https://finance.yahoo.com/quote/TRXC/chart

https://www.transenterix.com/company/about-us/

http://thestreetsweeper.org/author/anshul/

http://thestreetsweeper.org/transenterix-trxc-the-1-billion-dollar-joke/

http://thestreetsweeper.org/transenterix-trxc-the-1-billion-dollar-joke/
7/7/2019 TransEnterix (TRXC): The 1 Billion Dollar Joke – Street


thestreetsweeper.org/transenterix-trxc-the-1-billion-dollar-joke/ 3/11


Check out the company’s website here and then consider the six top issues that we believe ha


*PATHETIC SALES FIGURES


The company has sold just two of its Senhance Surgical Systems in the United States.


That’s right. Only two sold … and those account for half of the company’s all-time sales to date.


The first unit went to a high ranking teaching hospital, Florida Hospital Orlando, in November 20
teaching and research purposes.


Despite the efforts of a 17-member US sales team and $6 million in  sales and marketing costs, 
second unit at the end of May.


The unit went to University Medical Center New Orleans, a mid-sized academic research hospit
experience, according to US News & World Report 2017-18 Best Hospitals National Rankings.


The center’s highest ranking was “Average” in the nation in 3 procedures/conditions. It ranked “
website doesn’t even mention the Senhance purchase.


The UMC website does, however, mention frontrunner da Vinci, by Intuitive Surgical (ISRG).


In Europe, just two Senhance systems have sold in the three years since TransEnterix acquired 


Two more are under contract in Europe. (CEO Todd Pope referred to three total contracts durin
New Orleans sale that was then under contract.)


How do those Senhance sales compare with those of the da Vinci Surgical System, sold by ma


Let’s compare the numbers…


*INTUITIVELY OUTCLASSED


Intuitive shipped 185 systems last quarter… versus 2 TransEnterix systems.



https://www.transenterix.com/company/about-us/

https://www.businesswire.com/news/home/20171113005682/en/TransEnterix-Announces-Senhance-Sale-Agreement-Florida-Hospital

https://www.sec.gov/Archives/edgar/data/876378/000156459018011929/trxc-10q_20180331.htm

https://health.usnews.com/best-hospitals/area/la/medical-center-of-louisiana-6720027

https://seekingalpha.com/article/4171517-transenterixs-trxc-ceo-todd-pope-q1-2018-results-earnings-call-transcript?part=single

https://www.sec.gov/Archives/edgar/data/1035267/000103526718000048/isrg-20180331x10q.htm
7/7/2019 TransEnterix (TRXC): The 1 Billion Dollar Joke – Street


thestreetsweeper.org/transenterix-trxc-the-1-billion-dollar-joke/ 4/11


(Sources: Intuitive SEC filings, TransEnterix SEC filings, SA transcripts, TheStreetSweeper)


In the course of making those couple of sales last quarter, TransEnterix burned $12.3 million cas
recent quarter, Intuitive made $280 million.


Consider the totals to date for both companies:


(Sources: Company SEC filings, TheStreetSweeper)


TransEnterix also looks extremely overvalued in other matters. The price-to-sales ratio is comp


(Sources: Yahoo Finance, TheStreetSweeper)


If the Price/Sales matched, TransEnterix shares would be trading under $1, as they were about t


(Source: Yahoo)


It’s highly unlikely that many hospitals – which used da Vinci in 877,000 procedures worldwide la
of shucking their da Vinci systems in favor of an unfamiliar product.


Meanwhile, there are at least 13 other companies with introduced or clearly expressed plans fo


Johnson & Johnson and Google Inc. and their joint venture, Verb Surgical Inc.; Medtronic PLC.;


Medicaroid; MedRobotics Corp.; Auris Surgical Robotics;


Avatera Medical GmbH; Cambridge Medical Robotics;


meerecompany Inc.; Olympus Corp.; Samsung Corporation;


Smart Robot Technology Group; Titan Medical; and Wego Holding Co.


No wonder insiders have been selling TransEnterix stock…


*C SUITE EXECS YELL, “SELL, BABY, SELL!”



https://www.sec.gov/Archives/edgar/data/1035267/000103526718000048/isrg-20180331x10q.htm

https://www.sec.gov/Archives/edgar/data/876378/000156459018011929/trxc-10q_20180331.htm#ITEM_2_MANAGEMENTS_DISCUSSION_ANALYSIS_F

https://seekingalpha.com/article/4171517-transenterixs-trxc-ceo-todd-pope-q1-2018-results-earnings-call-transcript?part=single

https://www.sec.gov/Archives/edgar/data/876378/000156459018011929/trxc-10q_20180331.htm

https://www.sec.gov/Archives/edgar/data/1035267/000103526718000048/isrg-20180331x10q.htm

https://finance.yahoo.com/quote/TRXC/key-statistics?p=TRXC

https://finance.yahoo.com/quote/TRXC/chart
7/7/2019 TransEnterix (TRXC): The 1 Billion Dollar Joke – Street


thestreetsweeper.org/transenterix-trxc-the-1-billion-dollar-joke/ 5/11


None other than the chief financial officer/executive vice president unceremoniously dumped 


The executive who knows the company as well as anyone, CFO Joseph Slattery, decided to sell 


Mr. Slattery became nearly $1.2 million wealthier when he sold the shares on June 18  and 19  a


He is left with just 188,365 shares.


On June 1 , another C Suite executive unloaded more than half his ownership in the company.


Chief Operating Officer Anthony Fernando also unloaded more than half of his shares at $3.67 


(Source: Company SEC filing)


Meanwhile, insiders stand to receive a portion of 15 million recently  registered shares to be offe


*READY TO SELL: $100 MILLION WORTH OF STOCK


The company has its finger on the trigger to sell up to $100 million in debt securities, stock and w


This pile of dilution is effective, poised to damage existing shareholders’ value.


*PROMOTIONS, ANALYSTS, PRESENTATIONS GALORE


There’s really no news recently. Just fluff.


The stock reacted to the June 7  announcement that the company is seeking FDA clearance fo


th th


st


th



https://www.sec.gov/Archives/edgar/data/876378/000119312518175335/d580831ds8.htm

https://www.sec.gov/Archives/edgar/data/876378/000156459018011929/trxc-10q_20180331.htm
7/7/2019 TransEnterix (TRXC): The 1 Billion Dollar Joke – Street


thestreetsweeper.org/transenterix-trxc-the-1-billion-dollar-joke/ 6/11


laparoscopic surgeries (Becton, Dickinson and Company recently received FDA clearance), as 
various presentations.


The stock has been rather heavily promoted through Twitter:


StockTwits:



https://www.mpo-mag.com/contents/view_breaking-news/2017-06-20/fda-clears-bds-customizable-micro-laparoscopic-instruments
7/7/2019 TransEnterix (TRXC): The 1 Billion Dollar Joke – Street


thestreetsweeper.org/transenterix-trxc-the-1-billion-dollar-joke/ 7/11


Plus, the medtechy message board dated June 25, 2018, which innocently asks about a specta
comment on how the company is progressing with the SurgiBot FDA clearance timeline.


Umm, the company sold SurgiBot to a China-based company last December after the FDA boo


That’s right. The FDA rejected the SurgiBot marketing application TransEnterix announced on Ap
50%.


SurgiBot’s brief wallet-padding is shown below but will disappear thereafter for five years or if-
marketing … if ever.


Imagine what will happen to operating losses when the next financial report is filed, without tha


Meanwhile, a bullish call by RBC Capital apparently helped elevate the stock price in May, thoug
taken that stance because it has been a joint underwriter for TransEnterix since 2014.


Consider the mixed analyst ratings … 3 buy ratings and 2 holds, as well as the average price tar


 



https://seekingalpha.com/news/3174754-fda-rejects-transenterixs-surgibot-marketing-application-shares-54-percent

https://www.sec.gov/Archives/edgar/data/876378/000129993315001070/exhibit2.htm

https://www.sec.gov/Archives/edgar/data/876378/000119312514298363/d729762d10q.htm
7/7/2019 TransEnterix (TRXC): The 1 Billion Dollar Joke – Street


thestreetsweeper.org/transenterix-trxc-the-1-billion-dollar-joke/ 8/11


(Source: The Wall Street Journal)


The stock has already jumped way over the 12-month price target, suggesting a whopping 30%


So executives had better enjoy living the champagne and caviar lifestyle while they can …


* EXECUTIVE ENRICHMENT


The three top executives of this company – which has never made a profit and is unlikely to ma
jaw-dropping $5.4 million in combined compensation.


The filing is here on page 21. It shows CEO Todd Pope’s total compensation of $2.7 million.


The executive who recently sold 60% of his shares, CFO Joseph Slattery received $1.3 million com


And the recent unloader of about half his TransEnterix shares, Chief Operating Officer Anthony 
of $1.4 million.



https://www.sec.gov/Archives/edgar/data/876378/000119312518116910/d495552ddef14a.htm
7/7/2019 TransEnterix (TRXC): The 1 Billion Dollar Joke – Street


thestreetsweeper.org/transenterix-trxc-the-1-billion-dollar-joke/ 9/11


About Author


SONYA COLBERG


RELATED POSTS


*CONCLUSION


This is a reverse-merger, glorified promotion with $449 million in losses, trying to wiggle into a c
managers have found that getting the FDA’s marketing approval doesn’t guarantee sales and 
salaries) will require loads of cash likely resulting in potentially dilutive stock sales.


It makes no sense for this stock to fetch more than $2 per share … and that is very generous.


* Important Disclosure: The owners of TheStreetSweeper hold a short position in TRXC and stan


* Editor’s Note: As a matter of policy, TheStreetSweeper prohibits members of its editorial team 
that they cover. To contact Sonya Colberg, the author of this story, please send an email to stre


 Uncategorized


15



http://thestreetsweeper.org/author/anshul/

mailto:scolberg@thestreetsweeper.org

http://thestreetsweeper.org/category/uncategorized/

http://thestreetsweeper.org/obscene-insider-selling-of-galectin-therapeutics-galt-lost-confidence//#respond
7/7/2019 TransEnterix (TRXC): The 1 Billion Dollar Joke – Street


thestreetsweeper.org/transenterix-trxc-the-1-billion-dollar-joke/ 10/11


TheStreetSweeper releases a new
report on Galectin Therapeutics
(GALT)! The Norcross, Georgia biotech
is struggling in the biotech sector with
its candidate for NASH, non-alcoholic
steatohepatitis. After two failures to
meet primary endpoints, the company
intends to go into Phase III. Along with
the failed tests, Galectin is low on...


/  0 Comments


/  Sonya Colberg


OBSCENE INSIDER SELLING OF
GALECTIN THERAPEUTICS (GALT):
LOST CONFIDENCE?


Uncategorized


JUN 








Reviewer’s snubs, declining market
share and dicey technicals may soon
kick sand in Turtle Beach’s face. We
believe Turtle Beach (HEAR) has basked
long enough in its 150% run-up over
three days and is now changing
course. Exceeding Price Target On May
9, the gaming headset
company reported improved revenue
of $40.88 million,...


/  0 Comments


/  Sonya Colberg


TURTLE BEACH (HEAR): FUN IN THE
SUN IS OVER


Uncategorized


15
MAY 








Read More 


Read More 



http://thestreetsweeper.org/obscene-insider-selling-of-galectin-therapeutics-galt-lost-confidence//#respond

http://thestreetsweeper.org/author/anshul/

http://thestreetsweeper.org/obscene-insider-selling-of-galectin-therapeutics-galt-lost-confidence/

http://thestreetsweeper.org/category/uncategorized/

http://thestreetsweeper.org/turtle-beach-hear-fun-in-the-sun-is-over//#respond

http://thestreetsweeper.org/author/anshul/

http://thestreetsweeper.org/turtle-beach-hear-fun-in-the-sun-is-over/

http://thestreetsweeper.org/category/uncategorized/

http://thestreetsweeper.org/turtle-beach-hear-fun-in-the-sun-is-over/

http://thestreetsweeper.org/obscene-insider-selling-of-galectin-therapeutics-galt-lost-confidence/

http://thestreetsweeper.org/turtle-beach-hear-fun-in-the-sun-is-over/
7/7/2019 TransEnterix (TRXC): The 1 Billion Dollar Joke – Street


thestreetsweeper.org/transenterix-trxc-the-1-billion-dollar-joke/ 11/11


Comment


GIVE A REPLY


Comment Name


Email


© 2009-2018 TheStreetSweeper | All Rights Reserved Developed and Mana
